City Pharma Distributors Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 11-07-2024
- Paid Up Capital ₹ 0.10 M
as on 11-07-2024
- Company Age 3 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 45.00 Cr
as on 11-07-2024
About City Pharma Distributors
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹45.00 Cr.
Siddharth Upadhyay, Shashwat Nigam, and Kumara Shivalingu serve as directors at the Company.
- CIN/LLPIN
U24299KA2021PTC145022
- Company No.
145022
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Mar 2021
- Date of AGM
04 Aug 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Mysore, Karnataka, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at City Pharma Distributors?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Siddharth Upadhyay  | Additional Director | 27-Sep-2023 | Current |
| Shashwat Nigam | Additional Director | 27-Sep-2023 | Current |
| Kumara Shivalingu | Whole-Time Director | 08-Mar-2021 | Current |
Financial Performance and Corporate Structure Insights of City Pharma Distributors.
Enhance accessibility to City Pharma Distributors's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of City Pharma Distributors?
Unlock access to City Pharma Distributors's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Avenues Pharma Distributors Private LimitedActive 5 years 8 monthsSiddharth Upadhyay is a mutual person
- Sree Venkateshwara Medisolutions Private LimitedActive 4 years 8 months
Siddharth Upadhyay is a mutual person
- Sesha Balajee Medisolutions Private LimitedActive 5 years 4 months
Siddharth Upadhyay is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 03 Nov 2023 | ₹45.00 Cr | Open |
How Many Employees Work at City Pharma Distributors?
Unlock and access historical data on people associated with City Pharma Distributors, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of City Pharma Distributors, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped City Pharma Distributors's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
